logo-loader
viewPressure BioSciences, Inc.

Full interview: Pressure BioSciences PCT instrument deemed ‘essential’ by OB-GYN chair at gynecologic cancer meeting in in Brazil

Pressure BioSciences Inc (OTCMKTS:PBIO) CEO Ric Schumacher tells Proactive the Massachusetts-based company’s patented pressure cycling technology (PCT) was featured in a presentation at the Annual Meeting of the Gynecologic Cancer Society in Brazil. 

Schumacher explains the company’s PCT platform was used as part of a new process for analyzing proteins from cancer biopsy samples, and was excited to hear Dr. G. Larry Maxwell deem Pressure’ PCT instrument as an ‘essential requirement for our novel workflow in meeting our goals.’

Quick facts: Pressure BioSciences, Inc.

Price: 1.85 USD

OTCMKTS:PBIO
Market: OTCQB
Market Cap: $4.44 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Pressure BioSciences, Inc. named herein, including the promotion by the Company of Pressure BioSciences, Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Pressure BioSciences CEO sees potential opportunity to enter...

Pressure BioSciences Inc (OTCMKTS:PBIO) CEO Ric Schumacher tells Proactive the medical device company's signature Pressure Cycling Technology (PCT) platform has been highlighted by scientists in China and Australia, which Schumacher says could eventually propel the company into the clinical...

on 09/11/2019

2 min read